Exploring Dual-Targeted Therapy in the Management of Moderate to Severe Inflammatory Bowel Disease: A Retrospective Study

被引：0
作者：
Bhaskar, Sonya [1 ]
Makovich, Zachary [2 ]
Coughlin, Emily [1 ]
Mhaskar, Rahul [1 ]
Seminerio, Jennifer L. [2 ]
机构：
[1] Univ S Florida, Tampa, FL USA
[2] Univ S Florida, Morsani Coll Med, Tampa, FL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001034136.41707.fa
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1192
引用
收藏
页码：S847 / S847
页数：1
相关论文
共 50 条
[41]   Expert consensus paper on the use of Vedolizumab for the management of patients with moderate-to-severe Inflammatory Bowel Disease [J].
Armuzzi, Alessandro ;
Gionchetti, Paolo ;
Daperno, Marco ;
Danese, Silvio ;
Orlando, Ambrogio ;
Scribano, Maria Lia ;
Vecchi, Maurizio ;
Rizzello, Fernando .
DIGESTIVE AND LIVER DISEASE, 2016, 48 (04) :360-370
[42]   Dual-targeted therapy with apremilast and vedolizumab in pyoderma gangrenosum associated with Crohn's disease [J].
Vernero, Marta ;
Ribaldone, Davide Giuseppe ;
Cariti, Caterina ;
Ribero, Simone ;
Susca, Sara ;
Astegiano, Marco ;
Dapavo, Paolo .
JOURNAL OF DERMATOLOGY, 2020, 47 (06) :E216-E217
[43]   Effectiveness and Safety of Advanced Dual-Targeted Therapy in Refractory Perianal Crohn's Disease [J].
Fathallah, Nadia ;
Pagano, Mario ;
Houari, Mohamed Amine ;
Barre, Amelie ;
Atanasiu, Calina ;
Chambenois, Edouard ;
Nion-Larmurier, Isabelle ;
Morisset, Stephane ;
Kirchgesner, Julien ;
de Parades, Vincent .
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2025,
[44]   Aβ42 and ROS dual-targeted multifunctional nanocomposite for combination therapy of Alzheimer's disease [J].
Zhang, Liding ;
Cao, Kai ;
Xie, Jun ;
Liang, Xiaohan ;
Gong, Hui ;
Luo, Qingming ;
Luo, Haiming .
JOURNAL OF NANOBIOTECHNOLOGY, 2024, 22 (01)
[45]   Nanotechnology for Targeted Inflammatory Bowel Disease Therapy: Challenges and Opportunities [J].
Weng, Meng-Tzu ;
Hsiung, Chia-Yueh ;
Wei, Shu-Chen ;
Chen, Yunching .
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2024, 16 (05)
[46]   Stem Cells as Potential Targeted Therapy for Inflammatory Bowel Disease [J].
Gazouli, Maria ;
Roubelakis, Maria G. ;
Theodoropoulos, George E. .
INFLAMMATORY BOWEL DISEASES, 2014, 20 (05) :952-955
[47]   Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease [J].
Li, De-feng ;
Yang, Mei-feng ;
Xu, Hao-ming ;
Zhu, Min-zheng ;
Zhang, Yuan ;
Tian, Cheng-mei ;
Nie, Yu-qiang ;
Wang, Jian-yao ;
Liang, Yu-jie ;
Yao, Jun ;
Wang, Li-sheng .
JOURNAL OF MATERIALS CHEMISTRY B, 2022, 10 (31) :5853-5872
[48]   Recent Advances in Molecular Targeted Therapy for Inflammatory Bowel Disease [J].
Hisamatsu, Tadakazu ;
Miyoshi, Jun ;
Matsuura, Minoru .
INTERNAL MEDICINE, 2025,
[49]   The future of inflammatory bowel disease management: Combining progress in trial design with advances in targeted therapy [J].
Travis, Simon ;
Feagan, Brian G. ;
Rutgeerts, Paul ;
van Deventer, Sander .
JOURNAL OF CROHNS & COLITIS, 2012, 6 :S250-S259
[50]   Inflammatory bowel disease (IBD) in horses: a retrospective study exploring the value of different diagnostic approaches [J].
Boshuizen, Berit ;
Ploeg, Margreet ;
Dewulf, Jeroen ;
Klooster, Sanne ;
de Bruijn, Marco ;
Picavet, Marie-Therese ;
Palmers, Katrien ;
Plancke, Lukas ;
De Cock, Hilde ;
Theelen, Mathijs ;
Delesalle, Catherine .
BMC VETERINARY RESEARCH, 2018, 14
12345